Fanfei Kong

1.2k citations
26 papers · 626 indexed · h-index 15
Topics
Cancer-related molecular mechanisms research (11 papers)MicroRNA in disease regulation (8 papers)Circular RNAs in diseases (7 papers)

In The Last Decade

Fanfei Kong

26 papers receiving 622 citations

Peers

Fanfei Kong
Comparison fields: 5 of 73
  • Molecular Biology 422
  • Cancer Research 378
  • Oncology 151
  • Obstetrics and Gynecology 62
  • Immunology 49
Replace Kei Ihira with:
Kei Ihira Japan
Victoria Heredia-Soto Spain
Markéta Bednaříková Czechia
Betül T. Yesilyurt Belgium
Malee Warnnissorn Thailand
Bo‐Wei Han China
Mitsuyo Yoshida Japan
Cecilia Ahlin Sweden
Laura M S Seeber Netherlands
Sue Ghosh United States
Fanfei Kong relative to Kei Ihira Japan Kei Ihira's profile →
Citations per field
00.5×
Kei Ihira · 1×
Citations per year

Countries citing papers authored by Fanfei Kong

Since Specialization
Citations

This map shows the geographic impact of Fanfei Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanfei Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanfei Kong more than expected).

Fields of papers citing papers by Fanfei Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanfei Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanfei Kong. The network helps show where Fanfei Kong may publish in the future.

Co-authorship network of co-authors of Fanfei Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Fanfei Kong. A scholar is included among the top collaborators of Fanfei Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanfei Kong. Fanfei Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 11
3 23
4 25
5 1
6 29
7 44
8 13
9 46
10 14
11 20
12 50
13 37
14 53
15 4
16 21
17 2
18 7
19 21
20
[Proteasome inhibitors sensitize ovarian cancer cells to paclitaxel induced apoptosis].
1

About Fanfei Kong

Fanfei Kong is a scholar working on Cancer Research, Obstetrics and Gynecology and Oncology, having authored 26 papers that have together received 626 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (7 papers). The work is most often cited by research in Cancer Research (378 citations), Obstetrics and Gynecology (62 citations) and Molecular Biology (422 citations). Fanfei Kong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaoxin Ma, Hui Yang, Jian Ma, Rong Cong, Xiaoxin Ma, Cuicui Wang, Qi‐Jun Wu, Da Li, Di Yang and Qing Li. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cancer Letters and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026